SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: E_K_S who wrote (44168)8/31/2011 5:34:43 PM
From: benbuffett1 Recommendation  Read Replies (2) | Respond to of 78705
 
Not a pharmy but what about MDT. Not a screaming buy however trades at 12x e, growing dividend, decent cash flow. Currently trades at $35 per share



To: E_K_S who wrote (44168)9/1/2011 8:25:26 AM
From: Mr.Gogo  Respond to of 78705
 
I have Depomed. Increasing revenue from licensing. They are about to get approval for a drug for hot flashes. Good insider buying. No long term debt.

Regards, Georgi



To: E_K_S who wrote (44168)10/25/2011 9:21:22 PM
From: Paul Senior  Read Replies (2) | Respond to of 78705
 
EKS. Fwiw, I'm still not finding any healthcare stocks that are attractive to me now for a buy. I closed JNJ yesterday at $64. Have held a small position in TRIB, and I closed that one too. On today's pop in DGX, I sold out of that one also.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News